Identification of a novel human BCL-X promoter and exon
- 16 November 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (48) , 5534-5538
- https://doi.org/10.1038/sj.onc.1203949
Abstract
BCL-XL is a key anti-apoptotic BCL-2 family protein that is widely expressed in human cancer cells and is induced in response to diverse survival signals. The translation initiation codon for BCL-XL is located in BCL-X exon II and previous analyses have indicated that BCL-XL RNAs initiate close to the start of exon II or additionally contain a non-coding first exon (exon IA) spliced to exon II. Using 5′ RACE we have now identified a novel BCL-X non-coding exon (exon IB) which is spliced directly to exon II in place of exon IA. Exon IB-containing RNAs encoded BCL-XL and were detected in non-malignant lymphocytes and lymphoma cells from lymph node biopsies and were expressed at significant levels in cell lines derived from ovarian, colon and breast cancers. We identified two TATA-box sequences upstream of exon IB and demonstrated that surrounding genomic sequences contained strong promoter activity in lymphoma cells (approximately 300-fold active relative to controls). We have therefore identified a powerful new BCL-X promoter and a novel exon that contributes to BCL-XL expression.Keywords
This publication has 10 references indexed in Scilit:
- Bcl-2: Bax and Bcl-2: Bcl-x ratios by image cytometric quantitation of immunohistochemical expression in ovarian carcinoma: correlation with prognosisCytometry, 2000
- Selective regulation ofBcl-XLby a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignanciesGenes & Development, 1998
- Regulation of Bcl-xLexpression in human keratinocytes by cell–substratum adhesion and the epidermal growth factor receptorProceedings of the National Academy of Sciences, 1997
- The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.Genes & Development, 1996
- Predominant expression of the long isoform of Bcl‐x (Bcl‐xL) in human lymphomasBritish Journal of Haematology, 1996
- Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice.The Journal of Experimental Medicine, 1995
- Expression of bcl-xL can confer a multidrug resistance phenotypeBlood, 1995
- The role of bcl‐xL in CD40‐mediated rescue from anti‐μ‐induced apoptosis in WEHI‐231 B lymphoma cellsEuropean Journal of Immunology, 1995
- Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2.Proceedings of the National Academy of Sciences, 1994
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993